XML 64 R13.htm IDEA: XBRL DOCUMENT v3.23.4
Cash Equivalents and Marketable Securities
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]    
Cash Equivalents and Marketable Securities
4. Cash Equivalents and Marketable Securities
The following tables summarize the estimated fair value of the Company’s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):
 
     September 30, 2023  
     Amortized
Cost
     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated
Fair Value
 
Cash equivalents:
                                   
Money market funds
   $ 55,451      $ —        $ —        $ 55,451  
Commercial paper
     16,911        3        —          16,914  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total cash equivalents
   $ 72,362      $ 3      $ —        $ 72,365  
    
 
 
    
 
 
    
 
 
    
 
 
 
Marketable securities:
                                   
Commercial paper
   $ 90,272      $ —        $ (93    $ 90,179  
Corporate bonds
     22,849        1        (22      22,828  
U.S. government securities
     —          —          —          —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 113,121      $ 1      $ (115    $ 113,007  
    
 
 
    
 
 
    
 
 
    
 
 
 
   
     December 31, 2022  
     Amortized
Cost
     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated
Fair Value
 
Cash equivalents:
                                   
Money market funds
   $ 15,250      $ —        $ —        $ 15,250  
Commercial paper
     7,021        1        (2      7,020  
U.S. government securities
     3,736        —          (1      3,735  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total cash equivalents
   $ 26,007      $ 1      $ (3    $ 26,005  
    
 
 
    
 
 
    
 
 
    
 
 
 
Marketable securities:
                                   
Commercial paper
   $ 16,644      $ 2      $ (25    $ 16,621  
Corporate bonds
     3,738        —          (6      3,732  
U.S. government securities
     495        —          —          495  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 20,877      $ 2      $ (31    $ 20,848  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
The following table summarizes the
available-for-sale
securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of September 30, 2023 and December 31, 2022, aggregated by major security type and length of time in a continuous unrealized loss position:
 
     September 30, 2023  
     Less Than 12 Months     12 Months or
Longer
     Total  
     Fair
Value
     Unrealized
Losses
    Fair
Value
     Unrealized
Losses
     Fair
Value
     Unrealized
Losses
 
Commercial paper
   $ 78,820      $ (93   $ —        $ —        $ 78,820      $ (93
U.S. government securities
     —          —         —          —          —        $ —    
Corporate bonds
     18,373        (22     —          —          18,373        (22
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 97,193      $ (115   $ —        $ —        $ 97,193      $ (115
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
     December 31, 2022  
     Less Than 12 Months     12 Months or
Longer
     Total  
     Fair
Value
     Unrealized
Losses
    Fair
Value
     Unrealized
Losses
     Fair
Value
     Unrealized
Losses
 
Commercial paper
   $ 17,699      $ (27   $ —        $ —        $ 17,699      $ (27
U.S. government securities
     3,735        (1     —          —          3,735      $ (1
Corporate bonds
     3,732        (6     —          —          3,732        (6
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 25,166      $ (34   $ —        $ —        $ 25,166      $ (34
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
The Company evaluated its securities for credit losses and considered the decline in market value to be primarily attributable to current economic and market conditions and not to a credit loss or other factors. Additionally, the Company does not intend to sell the securities in an unrealized loss position and does not expect it will be required to sell the securities before recovery of the unamortized cost basis. As of September 30, 2023 and December 31, 2022, an allowance for credit losses had not been recognized. Given the Company’s intent and ability to hold such securities until recovery, and the lack of significant change in credit risk of these investments, the Company does not consider these marketable securities to be impaired as of September 30, 2023 and December 31, 2022.
The financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash deposits. Accounts at each of our three U.S. banking institutions are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per depositor. At September 30, 2023 and December 31, 2022, the Company had $16.9 million and $23.5 million, respectively, of U.S. cash deposits in excess of the FDIC insured limit. Uninsured foreign cash deposits were immaterial for both periods.
There were no realized gains or losses on marketable securities for the three and nine months ended September 30, 2023 and 2022. Interest on marketable securities is included in interest income. Accrued interest receivable on
available-for-sale
debt securities at September 30, 2023 and December 31, 2022 was $0.4 million and $0.1 million, respectively.
The following table summarizes the contractual maturities of the Company’s marketable securities at estimated fair value (in thousands):
 
     September 30,
2023
     December 31,
2022
 
Due in one year or less
   $ 102,518      $ 20,848  
Due thereafter
     10,489        —    
  
 
 
    
 
 
 
Total marketable securities
   $ 113,007      $ 20,848  
  
 
 
    
 
 
 
 
The Company may sell investments at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies marketable securities, including securities with maturities beyond twelve months as current
assets
.
4. Cash Equivalents and Marketable Securities
The following tables summarize the estimated fair value of the Company’s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):
 
    
December 31, 2022
 
    
Amortized
Cost
    
Gross
Unrealized
Gains
    
Gross
Unrealized
Losses
    
Estimated
Fair
Value
 
Cash equivalents:
           
Money market funds
   $ 15,250      $ —        $ —        $ 15,250  
Commercial paper
     7,021        1        (2      7,020  
U.S. government securities
     3,736        —          (1      3,735  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total cash equivalents
     26,007        1        (3      26,005  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2022
 
    
Amortized
Cost
    
Gross
Unrealized
Gains
    
Gross
Unrealized
Losses
    
Estimated
Fair Value
 
Marketable securities:
           
Commercial paper
     16,644        2        (25      16,621  
Corporate bonds
     3,738        —          (6      3,732  
U.S. government securities
     495        —          —          495  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 20,877      $ 2      $ (31    $ 20,848  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2021
 
    
Amortized
Cost
    
Gross
Unrealized
Gains
    
Gross
Unrealized
Losses
    
Estimated
Fair Value
 
Cash equivalents:
           
Money market funds
   $ 8,888      $ —        $ —        $ 8,888  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total cash equivalents
     8,888        —          —          8,888  
  
 
 
    
 
 
    
 
 
    
 
 
 
Marketable securities:
           
Commercial paper
     65,443        3        (34      65,412  
Corporate bonds
     12,581        —          (7      12,574  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 78,024      $ 3      $ (41    $ 77,986  
  
 
 
    
 
 
    
 
 
    
 
 
 
The following table summarizes the
available-for-sale
securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of December 31, 2022 and 2021, aggregated by major security type and length of time in a continuous unrealized loss position:
 
    
December 31, 2022
 
    
Less Than 12 Months
   
12 Months or Longer
    
Total
 
    
Fair Value
    
Unrealized
Losses
   
Fair Value
    
Unrealized
Losses
    
Fair Value
    
Unrealized
Losses
 
Commercial paper
   $ 17,699      $ (27   $ —        $ —        $ 17,699      $ (27
U.S. government securities
     3,735        (1     —          —          3,735        (1
Corporate bonds
     3,732        (6     —          —          3,732        (6
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 25,166      $ (34   $ —        $ —        $ 25,166      $ (34
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2021
 
    
Less Than 12 Months
   
12 Months or Longer
    
Total
 
    
Fair Value
    
Unrealized
Losses
   
Fair Value
    
Unrealized
Losses
    
Fair Value
    
Unrealized
Losses
 
Commercial paper
   $ 47,425      $ (34   $ —        $ —        $ 47,425      $ (34
Corporate bonds
     12,573        (7     —          —          12,573        (7
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 59,998      $ (41   $ —        $ —        $ 59,998      $ (41
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
The Company evaluated its securities for credit losses and considered the decline in market value to be primarily attributable to current economic and market conditions and not to a credit loss or other factors. Additionally, the Company does not intend to sell the securities in an unrealized loss position and does not expect they will be required to sell the securities before recovery of the unamortized cost basis. As of December 31, 2022 and 2021, an allowance for credit losses had not been recognized. Given the Company’s intent and ability to hold such securities until recovery, and the lack of significant change in credit risk of these investments, the Company does not consider these marketable securities to be impaired as of December 31, 2022 and 2021.
 
There were no realized gains or losses on marketable securities for the years ended December 31, 2022 and 2021. Interest on marketable securities is included in interest income. Accrued interest receivable on
available-for-sale
debt securities totaled $0.1 million and $0.1 million as of December 31, 2022 and 2021, respectively, and is excluded from the estimate of credit losses.
The following table summarizes the contractual maturities of the Company’s marketable securities at estimated fair value (in thousands):
 
    
December 31,
 
    
2022
    
2021
 
Due in one year or less
   $ 20,848      $ 77,986  
Due in 1 – 2 years
     —          —    
  
 
 
    
 
 
 
Total marketable securities
   $ 20,848      $ 77,986  
  
 
 
    
 
 
 
The Company may sell investments at any time for use in current operations even if they have not yet reached maturity. As a result, the
Company
classifies marketable securities, including securities with maturities beyond twelve months as current assets.